This form of AD results from mutations in three major genes: the amyloid precursor protein (APP) gene, the presenilin 1 (PSEN1) gene, and the presenilin 2 (PSEN2) gene, leading to an increase in β- and γ-secretase cleavage activity, respectively (Fig. 1). This evidence concerns the gene PSEN2 and Alzheimer disease.